Editorial: antigenic response to CT-P13 and infliximab originator in IBD shows similar epitope recognition-evidence from basic science supports safe switching to biosimilars. Authors' reply
Academic Article
Publication Date:
2018
Short description:
Editorial: antigenic response to CT-P13 and infliximab originator in IBD shows similar epitope recognition-evidence from basic science supports safe switching to biosimilars. Authors' reply / Goncalves, J; Magro, F; Danese, S; Lakatos, Pl; Ben-Horin, S. - In: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. - ISSN 0269-2813. - 48:5(2018), pp. 575-576. [10.1111/apt.14860]
Iris type:
1.1 Articolo in rivista
List of contributors:
Goncalves, J; Magro, F; Danese, S; Lakatos, Pl; Ben-Horin, S
Published in: